NYSE:PENMedical Equipment
Is It Too Late To Consider Penumbra After Its Strong 2025 Rally?
If you are wondering whether Penumbra is still worth buying after its big run up, or if the smart move now is to wait on the sidelines, you are in the right place.
The stock has climbed 1.2% over the last week, 9.5% over the past month, and 31.6% year to date, adding up to a 30.2% gain over 1 year and 68.6% over 5 years.
Those gains have been driven by ongoing optimism around its medical devices pipeline and growing adoption of its minimally invasive technologies in stroke and vascular...